Contained use
Final decisions taken in Belgium on contained use classified in risk class 3 or 4 of GMOs (LMOs) which are likely to be subject to transboundary movements in accordance with Article 11 of the Protocol, have to be notified to the BCH within 15 days of their adoption.
There are currently no such decisions.
Environmental releases (non-commercial)
According to Article 11 of the Protocol, Belgium shall inform the BCH of any final domestic decision regarding the deliberate release of GMOs (LMOs) in accordance with part B of Directive 2001/18/EC (see chapter "regulatory framework") that may be subject to transboundary movement for direct use as food or feed, or for processing, within 15 days of the adoption of that decision.
There are currently no such decisions.
The "Belgian Biosafety Server" provides a searchable Database with information about all deliberate releases of GMOs (LMOs) into the environment in Belgium for research and development or for any other purposes than placing on the market.
- Deliberate Releases of Transgenic Plants
- Deliberate Releases of Genetically Modified Micro-organisms
A Database of deliberate releases into the environment of the European Union of GMOs for any other purposes than placing on the market is also available on the Web site of the Joint Research Centre of the European Commission.
LMO-FFPs
Final decisions regarding LMO-FFPs are taken at EU level to allow these products to be used throughout the EU (see also the chapter "regulatory framework").
A list of GMOs (LMOs) that have been authorised for marketing in the European Union for direct use as food or feed, or for processing, is available from the BCH Central Portal.
Other commercial products
Final decisions regarding GMOs (LMOs) used as commercial products are taken at EU level to allow these products to be used throughout the EU (see also the chapter "regulatory framework").
A list of GMOs (LMOs) that have been authorised for marketing or submitted for marketing approval in the European Union is available from the European Commission Web Site and from the Web site of the Joint Research Centre of the European Commission.
OECD's Biotech Products Database: Products or regulated articles that have been approved for commercialisation in OECD Member countries.